<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="rmv1978-tbl-0004" xml:lang="en" orientation="portrait" position="float">
 <label>Table 4</label>
 <caption>
  <p>For the clinician—summary</p>
 </caption>
 <table frame="hsides" rules="groups">
  <col align="left" span="1"/>
  <col align="left" span="1"/>
  <thead valign="bottom">
   <tr style="border-bottom:solid 1px #000000">
    <th align="left" valign="bottom" rowspan="1" colspan="1">Adults and Children (Transmission Directly Via Mosquito Bite)</th>
    <th align="left" valign="bottom" rowspan="1" colspan="1">Neonates (Vertical Transmission)</th>
   </tr>
  </thead>
  <tbody valign="top">
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Patients in areas endemic for chikungunya, Zika, or dengue presenting with an acute neurological disorder should be investigated for all 3 arboviruses</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Neonates born to mothers experiencing symptoms of chikungunya infection near the time of delivery require admission and observation for signs of vertical transmission for at least 7 d postpartum, as they may be asymptomatic for the first few days of life</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Encephalitis is the most commonly reported neurological complication associated with chikungunya; encephalitis has a worse prognosis than encephalopathy alone; a CSF pleocytosis is not always seen</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Neonates born to mothers infected outside of the peripartum period are usually unaffected by chikungunya virus</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">In myelitis associated with chikungunya, CSF pleocytosis and magnetic resonance imaging changes are not always seen</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Caesarean section does not appear to be protective in vertical transmission of chikungunya</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Guillain‐Barré syndrome associated with chikungunya follows a similar course compared with other infections such as 
     <italic>Campylobacter jejuni</italic>; most patients recover after immunomodulatory treatment
    </td>
    <td align="left" valign="top" rowspan="1" colspan="1">Neonates infected with chikungunya should be followed up for at least 2 y, regardless of symptoms in the first week of life; the neurodevelopment of those without clinical encephalopathy at birth can still be affected</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Disease of both the central and peripheral nervous systems in the same patient can be seen in association with chikungunya infection</td>
    <td align="left" valign="top" rowspan="1" colspan="1"/>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Ophthalmological complications associated with chikungunya have been reported both at the time of infection and up to 12 wk after; some reports describe treating with steroids, recovery is variable</td>
    <td align="left" valign="top" rowspan="1" colspan="1"/>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Following chikungunya infection, complications of other organs can also occur at the same time as disease of the nervous system; such cases should be managed using a multidisciplinary approach</td>
    <td align="left" valign="top" rowspan="1" colspan="1"/>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">There is currently no available antiviral treatment or vaccine for chikungunya</td>
    <td align="left" valign="top" rowspan="1" colspan="1"/>
   </tr>
  </tbody>
 </table>
</table-wrap>
